These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN. J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710 [Abstract] [Full Text] [Related]
3. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. Takano T, Clish CB, Gronert K, Petasis N, Serhan CN. J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977 [Abstract] [Full Text] [Related]
4. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). Titos E, Chiang N, Serhan CN, Romano M, Gaya J, Pueyo G, Clària J. Am J Physiol; 1999 Nov 15; 277(5):C870-7. PubMed ID: 10564079 [Abstract] [Full Text] [Related]
5. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. O'Meara YM, Brady HR. Kidney Int Suppl; 1997 Mar 15; 58():S56-61. PubMed ID: 9067945 [Abstract] [Full Text] [Related]
6. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Clària J, Serhan CN. Proc Natl Acad Sci U S A; 1995 Oct 10; 92(21):9475-9. PubMed ID: 7568157 [Abstract] [Full Text] [Related]
7. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. Planagumà A, Titos E, López-Parra M, Gaya J, Pueyo G, Arroyo V, Clària J. FASEB J; 2002 Dec 10; 16(14):1937-9. PubMed ID: 12368230 [Abstract] [Full Text] [Related]
8. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN. J Exp Med; 1997 May 05; 185(9):1693-704. PubMed ID: 9151906 [Abstract] [Full Text] [Related]
9. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN. J Immunol; 2003 Mar 01; 170(5):2688-94. PubMed ID: 12594298 [Abstract] [Full Text] [Related]
10. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Brezinski DA, Nesto RW, Serhan CN. Circulation; 1992 Jul 01; 86(1):56-63. PubMed ID: 1617790 [Abstract] [Full Text] [Related]
11. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion. Nigam S, Fiore S, Luscinskas FW, Serhan CN. J Cell Physiol; 1990 Jun 01; 143(3):512-23. PubMed ID: 2162850 [Abstract] [Full Text] [Related]
12. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Serhan CN. Prostaglandins Leukot Essent Fatty Acids; 2005 Jun 01; 73(3-4):141-62. PubMed ID: 16005201 [Abstract] [Full Text] [Related]
13. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. Romano M, Maddox JF, Serhan CN. J Immunol; 1996 Sep 01; 157(5):2149-54. PubMed ID: 8757340 [Abstract] [Full Text] [Related]
14. Lipoxin generation by permeabilized human platelets. Romano M, Serhan CN. Biochemistry; 1992 Sep 08; 31(35):8269-77. PubMed ID: 1381961 [Abstract] [Full Text] [Related]
15. Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. Pouliot M, Serhan CN. J Periodontal Res; 1999 Oct 08; 34(7):370-3. PubMed ID: 10685363 [Abstract] [Full Text] [Related]
16. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. Hachicha M, Pouliot M, Petasis NA, Serhan CN. J Exp Med; 1999 Jun 21; 189(12):1923-30. PubMed ID: 10377187 [Abstract] [Full Text] [Related]
17. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Papayianni A, Serhan CN, Brady HR. J Immunol; 1996 Mar 15; 156(6):2264-72. PubMed ID: 8690917 [Abstract] [Full Text] [Related]
18. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN. J Clin Invest; 1999 Aug 15; 104(3):309-16. PubMed ID: 10430612 [Abstract] [Full Text] [Related]
19. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Clish CB, O'Brien JA, Gronert K, Stahl GL, Petasis NA, Serhan CN. Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):8247-52. PubMed ID: 10393980 [Abstract] [Full Text] [Related]
20. Lipoxin receptors. Romano M, Recchia I, Recchiuti A. ScientificWorldJournal; 2007 Sep 01; 7():1393-412. PubMed ID: 17767357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]